Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2021 Filed Dec 3, 2021 01:45 UTC |
BVF PARTNERS L P/ILDirector · 10% owner
BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
BVF I GP LLCSee Explanation of Responses
BIOTECHNOLOGY VALUE FUND II LPSee Explanation of Responses
BVF II GP LLCSee Explanation of Responses
Biotechnology Value Trading Fund OS LPSee Explanation of Responses
BVF Partners OS Ltd.See Explanation of Responses
BVF GP HOLDINGS LLC10% owner
BVF INC/IL10% owner
LAMPERT MARK N10% owner
|
PurchaseCommon stock, $0.0001 par value | 341,977 | $9.39 | $3,211,266.62 |
DisclosureSEC source: 0001193805-21-001684 · e621128_4-olma.xml · nonDerivative · entry 2 BVF PARTNERS L P/IL · CIK 0001055947 · Director · 10% owner BIOTECHNOLOGY VALUE FUND L P · CIK 0000918923 · See Explanation of Responses BVF I GP LLC · CIK 0001803805 · See Explanation of Responses BIOTECHNOLOGY VALUE FUND II LP · CIK 0001102444 · See Explanation of Responses BVF II GP LLC · CIK 0001803806 · See Explanation of Responses Biotechnology Value Trading Fund OS LP · CIK 0001660683 · See Explanation of Responses BVF Partners OS Ltd. · CIK 0001660684 · See Explanation of Responses BVF GP HOLDINGS LLC · CIK 0001803809 · 10% owner BVF INC/IL · CIK 0001056807 · 10% owner LAMPERT MARK N · CIK 0001233840 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,865,242 F1 · security: This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF I GP LLC ("BVF GP"), BVF II GP LLC ("BVF2 GP"), BVF GP Holdings LLC ("BVF GPH"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F3 · ownership.direct: Securities owned directly by BVF2. As the general partner of BVF2, BVF2 GP may be deemed to beneficially own the securities owned directly by BVF2. As the sole member of BVF2 GP, BVF GPH may be deemed to beneficially own securities owned directly by BVF2. As the investment manager of BVF2, Partners may be deemed to beneficially own the securities owned directly by BVF2. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF2. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF2. Read SEC document |
| November 30, 2021 Filed Dec 3, 2021 01:45 UTC |
BVF PARTNERS L P/ILDirector · 10% owner
BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
BVF I GP LLCSee Explanation of Responses
BIOTECHNOLOGY VALUE FUND II LPSee Explanation of Responses
BVF II GP LLCSee Explanation of Responses
Biotechnology Value Trading Fund OS LPSee Explanation of Responses
BVF Partners OS Ltd.See Explanation of Responses
BVF GP HOLDINGS LLC10% owner
BVF INC/IL10% owner
LAMPERT MARK N10% owner
|
PurchaseCommon stock, $0.0001 par value | 362,430 | $9.39 | $3,403,326.43 |
DisclosureSEC source: 0001193805-21-001684 · e621128_4-olma.xml · nonDerivative · entry 1 BVF PARTNERS L P/IL · CIK 0001055947 · Director · 10% owner BIOTECHNOLOGY VALUE FUND L P · CIK 0000918923 · See Explanation of Responses BVF I GP LLC · CIK 0001803805 · See Explanation of Responses BIOTECHNOLOGY VALUE FUND II LP · CIK 0001102444 · See Explanation of Responses BVF II GP LLC · CIK 0001803806 · See Explanation of Responses Biotechnology Value Trading Fund OS LP · CIK 0001660683 · See Explanation of Responses BVF Partners OS Ltd. · CIK 0001660684 · See Explanation of Responses BVF GP HOLDINGS LLC · CIK 0001803809 · 10% owner BVF INC/IL · CIK 0001056807 · 10% owner LAMPERT MARK N · CIK 0001233840 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,755,093 F1 · security: This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF I GP LLC ("BVF GP"), BVF II GP LLC ("BVF2 GP"), BVF GP Holdings LLC ("BVF GPH"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F2 · ownership.direct: Securities owned directly by BVF. As the general partner of BVF, BVF GP may be deemed to beneficially own the securities owned directly by BVF. As the sole member of BVF GP, BVF GPH may be deemed to beneficially own securities owned directly by BVF. As the investment manager of BVF, Partners may be deemed to beneficially own the securities owned directly by BVF. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 22:34 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 400 | $24.76 | $9,904.00 |
DisclosureSEC source: 0001415889-21-005622 · form4-12012021_021248.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $24.76, and the range of prices were between $24.75 and $24.80. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,417 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005174 · form4-11122021_021156.xml · derivative · entry 5 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,253 Underlying: Common Stock · 22,417 shares Expires 2030-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One thirty-sixth of the remaining number of shares subject to the option vest on a monthly basis, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-005174 · form4-11122021_021156.xml · derivative · entry 4 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,791 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 27,668 | $26.88 | $743,715.84 |
DisclosureSEC source: 0001415889-21-005174 · form4-11122021_021156.xml · nonDerivative · entry 3 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: T he weighted average sale price for the transaction reported was $26.88, and the range of prices was between $26.56 and $27.32. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 22,417 | $19.00 | $425,923.00 |
DisclosureSEC source: 0001415889-21-005174 · form4-11122021_021156.xml · nonDerivative · entry 2 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 5,251 | $2.06 | $10,838.06 |
DisclosureSEC source: 0001415889-21-005174 · form4-11122021_021156.xml · nonDerivative · entry 1 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:33 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 4,555 | $28.20 | $128,451.00 |
DisclosureSEC source: 0001415889-21-004934 · form4-10212021_011011.xml · nonDerivative · entry 2 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $28.20, and the range of prices were between $28.00 and $28.63. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:33 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 7,445 | $27.85 | $207,343.25 |
DisclosureSEC source: 0001415889-21-004934 · form4-10212021_011011.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,056,101 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $27.85, and the range of prices were between $27.60 and $28.00. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:44 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001415889-21-004885 · form4-10152021_031031.xml · derivative · entry 4 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,316 Underlying: Common Stock · 5,000 shares Expires 2030-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:44 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 351 | $31.17 | $10,940.67 |
DisclosureSEC source: 0001415889-21-004885 · form4-10152021_031031.xml · nonDerivative · entry 3 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,514 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $31.17, and the range of prices were between $31.00 and $31.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:44 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 4,649 | $30.42 | $141,422.58 |
DisclosureSEC source: 0001415889-21-004885 · form4-10152021_031031.xml · nonDerivative · entry 2 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,865 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $30.42, and the range of prices were between $30.00 and $30.99. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:44 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 5,000 | $4.82 | $24,120.00 |
DisclosureSEC source: 0001415889-21-004885 · form4-10152021_031031.xml · nonDerivative · entry 1 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:53 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-004829 · form4-10122021_031058.xml · derivative · entry 4 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,042 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:53 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 3,146 | $28.19 | $88,685.74 |
DisclosureSEC source: 0001415889-21-004829 · form4-10122021_031058.xml · nonDerivative · entry 3 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $28.19, and the range of prices were between $27.88 and $28.62. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:53 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 2,105 | $27.47 | $57,824.35 |
DisclosureSEC source: 0001415889-21-004829 · form4-10122021_031058.xml · nonDerivative · entry 2 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,936 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $27.47, and the range of prices were between $26.88 and $27.87. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:53 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 5,251 | $2.06 | $10,838.06 |
DisclosureSEC source: 0001415889-21-004829 · form4-10122021_031058.xml · nonDerivative · entry 1 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 23:56 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001415889-21-004613 · form4-09292021_040935.xml · derivative · entry 3 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,316 Underlying: Common Stock · 1,085 shares Expires 2030-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 23:56 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 1,085 | $30.07 | $32,625.95 |
DisclosureSEC source: 0001415889-21-004613 · form4-09292021_040935.xml · nonDerivative · entry 2 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,514 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 23:56 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 1,085 | $4.82 | $5,234.04 |
DisclosureSEC source: 0001415889-21-004613 · form4-09292021_040935.xml · nonDerivative · entry 1 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 22:19 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 12,000 | $26.30 | $315,600.00 |
DisclosureSEC source: 0001415889-21-004513 · form4-09212021_030906.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,063,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $26.30, and the range of prices were between $25.95 and $26.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 00:07 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-004370 · form4-09132021_050950.xml · derivative · entry 3 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,293 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 00:07 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 5,251 | $29.38 | $154,274.38 |
DisclosureSEC source: 0001415889-21-004370 · form4-09132021_050950.xml · nonDerivative · entry 2 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $29.38, and the range of prices were between $29.01 and $29.59. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 00:07 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 5,251 | $2.06 | $10,838.06 |
DisclosureSEC source: 0001415889-21-004370 · form4-09132021_050950.xml · nonDerivative · entry 1 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,631 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · derivative · entry 6 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972,401 Underlying: Common Stock · 2,631 shares Expires 2030-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 2,631 | $30.00 | $78,930.00 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · nonDerivative · entry 4 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,514 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 2,631 | $4.82 | $12,691.94 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · nonDerivative · entry 3 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 413 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · derivative · entry 5 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975,032 Underlying: Common Stock · 413 shares Expires 2030-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 413 | $30.08 | $12,423.04 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · nonDerivative · entry 2 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,274 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $30.08, and the range of prices were between $30.00 and $30.12. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:25 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 413 | $4.82 | $1,992.31 |
DisclosureSEC source: 0001415889-21-004306 · form4-09092021_010907.xml · nonDerivative · entry 1 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:16 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 871 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001415889-21-004247 · form4-09032021_020903.xml · derivative · entry 3 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975,445 Underlying: Common Stock · 871 shares Expires 2030-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:16 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 871 | $30.05 | $26,173.55 |
DisclosureSEC source: 0001415889-21-004247 · form4-09032021_020903.xml · nonDerivative · entry 2 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,274 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $30.05, and the range of prices were between $30.01 and $30.15. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:16 UTC |
Bohen SeanDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 871 | $4.82 | $4,201.70 |
DisclosureSEC source: 0001415889-21-004247 · form4-09032021_020903.xml · nonDerivative · entry 1 Bohen Sean · CIK 0001831218 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,625 shares acquired under the issuer's Employee Stock Purchase Plan on May 14, 2021. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 01:14 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 12,000 | $24.97 | $299,640.00 |
DisclosureSEC source: 0001415889-21-004029 · form4-08202021_060804.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $24.97, and the range of prices were between $24.75 and $25.46. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:05 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-003861 · form4-08112021_030846.xml · derivative · entry 4 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,544 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:05 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 60 | $26.17 | $1,570.20 |
DisclosureSEC source: 0001415889-21-003861 · form4-08112021_030846.xml · nonDerivative · entry 3 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:05 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 5,191 | $25.70 | $133,408.70 |
DisclosureSEC source: 0001415889-21-003861 · form4-08112021_030846.xml · nonDerivative · entry 2 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $25.70, and the range of prices were between $25.11 and $26.10. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:05 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 5,251 | $2.06 | $10,838.06 |
DisclosureSEC source: 0001415889-21-003861 · form4-08112021_030846.xml · nonDerivative · entry 1 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 21:29 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 4,123 | $25.63 | $105,672.49 |
DisclosureSEC source: 0001415889-21-003664 · form4-07212021_020727.xml · nonDerivative · entry 2 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $25.63, and the range of prices were between $25.14 and $26.10. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 21:29 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 7,877 | $24.83 | $195,585.91 |
DisclosureSEC source: 0001415889-21-003664 · form4-07212021_020727.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,669 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $24.83, and the range of prices were between $24.75 and $24.95. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 22:27 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-003598 · form4-07132021_030746.xml · derivative · entry 4 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,795 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 22:27 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 1,392 | $27.00 | $37,584.00 |
DisclosureSEC source: 0001415889-21-003598 · form4-07132021_030746.xml · nonDerivative · entry 3 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $27.00, and the range of prices were between $26.80 and $27.16. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 22:27 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 3,859 | $26.33 | $101,607.47 |
DisclosureSEC source: 0001415889-21-003598 · form4-07132021_030746.xml · nonDerivative · entry 2 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,182 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $26.33, and the range of prices were between $25.74 and $26.72. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 22:27 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionCommon Stock | 5,251 | $2.06 | $10,838.06 |
DisclosureSEC source: 0001415889-21-003598 · form4-07132021_030746.xml · nonDerivative · entry 1 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 23:05 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 600 | $26.30 | $15,780.00 |
DisclosureSEC source: 0001415889-21-003129 · form4-06212021_040621.xml · nonDerivative · entry 3 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: 2. The weighted average sale price for the transaction reported was $26.30, and the range of prices were between $26.19 and $26.99. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 23:05 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 1,990 | $25.59 | $50,924.10 |
DisclosureSEC source: 0001415889-21-003129 · form4-06212021_040621.xml · nonDerivative · entry 2 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $25.59, and the range of prices were between $25.16 and $26.14. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 23:05 UTC |
Harmon CyrusDirector · CHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 9,410 | $24.54 | $230,921.40 |
DisclosureSEC source: 0001415889-21-003129 · form4-06212021_040621.xml · nonDerivative · entry 1 Harmon Cyrus · CIK 0001831410 · Director · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,136 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $24.54, and the range of prices were between $24.18 and $25.14. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:30 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,251 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001415889-21-002957 · form4-06112021_010653.xml · derivative · entry 5 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,046 Underlying: Common Stock · 5,251 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:30 UTC |
Horn KinneyCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 2,787 | $29.97 | $83,526.39 |
DisclosureSEC source: 0001415889-21-002957 · form4-06112021_010653.xml · nonDerivative · entry 4 Horn Kinney · CIK 0001831215 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $29.97, and the range of prices were between $29.82 and $30.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.